Core Insights - Zacks Premium provides tools for investors to enhance their stock market engagement and confidence through various resources [1] Zacks Style Scores - Zacks Style Scores are indicators that assist investors in selecting stocks likely to outperform the market within 30 days, rated from A to F based on value, growth, and momentum characteristics [2] - The Value Score focuses on identifying undervalued stocks using financial ratios like P/E, PEG, and Price/Sales [3] - The Growth Score emphasizes a company's financial health and future outlook, analyzing projected and historical earnings, sales, and cash flow [4] - The Momentum Score helps investors capitalize on price trends by evaluating recent price changes and earnings estimate shifts [5] - The VGM Score combines the three Style Scores to identify stocks with attractive value, strong growth forecasts, and promising momentum, serving as a useful tool alongside the Zacks Rank [6] Zacks Rank and Style Scores Integration - The Zacks Rank is a proprietary model that uses earnings estimate revisions to simplify portfolio building, with 1 (Strong Buy) stocks achieving an average annual return of +23.81% since 1988, significantly outperforming the S&P 500 [7] - With over 800 top-rated stocks available, the Style Scores help investors narrow down their choices to align with their investment goals [8] - To maximize returns, investors should target stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B, while also considering stocks with a 3 rank if they possess high Style Scores [9][10] Company Spotlight: Maximus (MMS) - Maximus, headquartered in Reston, VA, operates globally in government health and human services, employing over 39,600 individuals across multiple countries [11] - Maximus holds a Zacks Rank of 2 (Buy) and a VGM Score of A, making it a strong candidate for growth investors [12] - The company is projected to achieve a year-over-year earnings growth of 12% for the current fiscal year, with recent earnings estimates revised upward [12]
Maximus (MMS) is a Top-Ranked Growth Stock: Should You Buy?